Azacitidine and Iadademstat Therapies in MDS and AML

Created using ChatSlide

This training session focuses on enhancing clinical skills by exploring the use of Azacitidine and Iadademstat in therapies for Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). We will delve into their mechanisms, examining Azacitidine's hypomethylation effects and Iadademstat's role in AML treatment. Insights from pivotal trials like CALGB 9221 and ALICE-2 will be highlighted, emphasizing treatment outcomes such as response rates and survival metrics. The session will also...